World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...

The companies didn’t provide details, but said global regulatory filings are now planned for the therapy, an oligonucleotide meant to provide “functional cures” for chronic hepatitis B infections.

Bristol-Myers Squibb's key drugs are losing patent protection, while more recently launched drugs are struggling to meet peak revenue expectations. Learn more about BMY stock here.

It started slowly, with handfuls of hair circling the plug hole in the shower. Then eventually British bodybuilder Tracy Kiss began to notice she could see her scalp when her hair was wet. “I always ...

LEXINGTON, Ky. – Twenty consecutive years. In 2005, the National Collegiate Athletic Association began measuring a Graduation Success Rate for its member schools’ athletics departments. The initial ...

Buffalo and Kansas City rank among the most efficient NFL offenses, but the Colts continue to reign supreme with Indiana Jones under center. Offensive Success Rate is a simple but consequential metric ...

The pass rate for the final level of the chartered financial analyst exam — in which test-takers are allowed a choice of specialty — rose slightly while still remaining lower than the historic average ...

NEW YORK -- The NFL appears to have saved the kickoff after being on life support for years. Now its attention turns to the onside kick, which has been terminal for years. In its presentation to NFL ...

Let's throw out the records for the moment. How well is your favorite team really playing after Week 7? As we hit the midway point of the season, and conference play is heating up, which teams are ...

ONO-4578, an EP4 antagonist, in combination with Opdivo and chemotherapy demonstrated a significant prolongation of progression-free survival compared with placebo in combination with Opdivo and ...

Bristol Myers (BMY) has a strong oncology portfolio comprising blockbuster immune-oncology drug Opdivo, Opdivo Qvantig, and Yervoy, among others. Opdivo is a key drug in BMY’s Growth Portfolio that is ...